Human XPE/DDB2 Antibody
R&D Systems, part of Bio-Techne | Catalog # AF3297
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Cited:
Human
Applications
Validated:
Western Blot
Cited:
Western Blot, Immunocytochemistry
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Product Specifications
Immunogen
E. coli-derived recombinant human XPE/DDB2
Met1-Lys427
Accession # Q92466
Met1-Lys427
Accession # Q92466
Specificity
Detects human XPE/DDB2 in Western blots.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for Human XPE/DDB2 Antibody
Detection of Human XPE/DDB2 by Western Blot.
Western blot shows lysates of HeLa human cervical epithelial carcinoma cell line and U2OS human osteosarcoma cell line. PVDF membrane was probed with 0.5 µg/mL of Human XPE/DDB2 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3297) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF017). A specific band was detected for XPE/DDB2 at approximately 45 kDa (as indicated). This experiment was conducted using Immunoblot Buffer Group 1.Detection of XPE/DDB2 by Western Blot
MG132-induced DDB2 accumulation depends on the proteasome subunit PSMD14. (a) Immunoblot analyses validating depletion of the proteasome subunits. U2OS cells were transfected with negative control siRNA (siNC) or siRNA targeting PSMD14 (siPSMD14), and cell lysates were prepared after incubation for the indicated number of days. All subsequent experiments were performed on the second day of post-transfection. (b,c) Cells expressing DDB2-mKO1 were treated with siNC or siPSMD14, and then incubated for 6 h in the presence or absence of 5 µM MG132. Based on live-cell images acquired with a confocal laser scanning microscope (b), percentages of cells with subnuclear DDB2 accumulation were measured as in Fig. 2d. (d) Immunoblot analyses validating expression of the XPC, DDB2, and PSMD14 proteins in the indicated cell lines. (e) Recruitment of PSMD14-mKO1 to local DNA damage was assessed quantitatively in the indicated cell lines. ** P < 0.01. (f) Representative live-cell images of PSMD14-mKO1 localization in cells that were mock-treated or treated for 6 h in the presence of 5 µM MG132 or 10 µM lactacystin. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/33184426), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of XPE/DDB2 by Western Blot
Real-time monitoring of recruitment of mKO1-RAD23B to local DNA damage. (a) Immunoblot analyses of endogenous and ectopically expressed XPC, DDB2, and RAD23B in the indicated cell lines. (b,c) Local DNA damage was induced in the indicated cell lines by three-photon absorption with an infrared femtosecond laser. Relative mKO1 intensities at damaged sites were quantitatively assessed over time. Inset in (b) shows enlargement of the graph in the early time range. The statistical significance assessed for the last time point is shown. *** P < 0.001. (d) Immunoblot analyses validating the effects of MLN4924. U2OS cells were pre-incubated for 2 h in the presence or absence of 1 µM MLN4924, and then irradiated with UVC at 10 J/m2 (or mock-irradiated) and further incubated for 1 h with or without MLN4924. Asterisk indicates non-specific reaction of the anti-XPC antibody. e The indicated cell lines were pre-treated for 2 h with or without 1 µM MLN4924, and recruitment of mKO1-RAD23B to local DNA damage was measured as in panels b and c. *** P < 0.001. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/33184426), licensed under a CC-BY license. Not internally tested by R&D Systems.Applications for Human XPE/DDB2 Antibody
Application
Recommended Usage
Western Blot
0.5 µg/mL
Sample: HeLa human cervical epithelial carcinoma cell line and U2OS human osteosarcoma cell line
Sample: HeLa human cervical epithelial carcinoma cell line and U2OS human osteosarcoma cell line
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: XPE/DDB2
Xeroderma Pigmentosum complementation group E (XPE) patients are defective in a heterodimer of damage-specific DNA-binding activity (DDB1/DDB2). DDB2 is a 48 kDa protein upregulated in cells exposed to ultraviolet light. XP patients exhibit hypersensitivity to ultraviolet light and have a heightened incidence of skin cancer.
Long Name
Xeroderma Pigmentosum E
Alternate Names
DDB2, XP5
Gene Symbol
DDB2
UniProt
Additional XPE/DDB2 Products
Product Documents for Human XPE/DDB2 Antibody
Product Specific Notices for Human XPE/DDB2 Antibody
For research use only
Loading...
Loading...
Loading...
Loading...